Mechanisms in endocrinology: Geneticsof FSH action - A 2014-and-beyond view

European Journal of Endocrinology

Volumn 170, Issue 3, 2014, Pages

  Simoni, Manuela ^a,b   Casarini, Livio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b AUSL Modena   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; FOLLITROPIN BETA SUBUNIT; FOLLITROPIN RECEPTOR; GONADOTROPIN; RECOMBINANT FOLLITROPIN;

FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC TRANSCRIPTION; GENOTYPE; HAPLOTYPE; HUMAN; INFERTILITY THERAPY; MALE INFERTILITY; NONHUMAN; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHARMACOGENETICS; PREGNANCY RATE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPERMATOGENESIS; SYSTEMATIC REVIEW; ADULT; ANIMAL; BLOOD; FEMALE; GENETICS; INFERTILITY; MALE; METHODOLOGY; PHYSIOLOGY; POPULATION GENETICS;

ADULT; ANIMALS; FEMALE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GENE FREQUENCY; GENETICS, POPULATION; HUMANS; INFERTILITY; MALE; OVULATION INDUCTION; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, FSH; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84896257707     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0624     Document Type: Review

References (90)

1. Foresta C, Selice R, Ferlin A, Arslan P & Garolla A. Hormonal treatment of male infertility: FSH. Reproductive Biomedicine Online 2007 15 666-672. (doi:10.1016/S1472-6483(10)60533-0)
2. De Leo V, Musacchio MC, Di Sabatino A, Tosti C, Morgante G & Petraglia F. Present and future of recombinant gonadotropins in reproductive medicine. Current Pharmaceutical Biotechnology 2012 13 379-391. (doi:10.2174/138920112799361918)
3. Martins WP, Vieira AD, Figueiredo JB & Nastri CO. FSH replaced by low-dose hCG in the late follicular phase versus continued FSH for assisted reproductive techniques. Cochrane Database of Systematic Reviews 2013 3 CD010042. (doi:10.1002/14651858.CD010042.pub2)
4. Albuquerque LE, Tso LO, Saconato H, Albuquerque MC & Macedo CR. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Cochrane Database of Systematic Reviews 2013 1 CD002808. (doi:10.1002/14651858. CD002808.pub3)
5. Pouwer AW, Farquhar C & Kremer JA. Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2012 6 CD009577. (doi:10.1002/14651858.CD009577.pub2)
6. Maheshwari A, Gibreel A, Siristatidis CS & Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database of Systematic Reviews 2011 8 CD006919. (doi:10.1002/14651858.CD006919.pub3)
7. Bühler K, Bals-Pratsch M, Blumenauer V, Dahncke W, Felberbaum R, Fiedler K, Gnoth C, Happel L, Krüssel JS, Kupka MS et al. DIR Annual 2011 - German IVF-Registry. Journal für Reproduktionsmedizin und Endokrinolologie 2012 9 456-484.
8. Gromoll J & Simoni M. Genetic complexity of FSH receptor function. Trends in Endocrinology and Metabolism 2005 16 368-373. (doi:10.1016/j.tem.2005. 05.011)
9. Simoni M, Gromoll J & Nieschlag E. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Reviews 1997 18 739-773. (doi:10.1210/er.18.6.739)
10. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E & Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. Journal of Clinical Endocrinology and Metabolism 2000 85 3365-3369. (doi:10.1210/jc.85.9.3365)
11. Grigorova M, Punab M, Ausmees K & Laan M. FSHB promoter polymorphism within evolutionary conserved element is associated with serum FSH level in men. Human Reproduction 2008 23 2160-2166. (doi:10.1093/humrep/den216)
12. Casarini L, Pignatti E & Simoni M. Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Reviews in Endocrine & Metabolic Disorders 2011 12 303-321. (doi:10.1007/s11154-011- 9192-2)
13. Altmäe S, Hovatta O, Stavreus-Evers A & Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Human Reproduction Update 2011 17 813-828. (doi:10.1093/humupd/dmr034)
14. Laan M, Grigorova M & Huhtaniemi IT. Pharmacogenetics of follicle-stimulating hormone action. Current Opinion in Endocrinology, Diabetes, and Obesity 2012 19 220-227. (doi:10.1097/MED.0b013e3283534b11)
15. La Marca A, Sighinolfi G, Argento C, Grisendi V, Casarini L, Volpe A & Simoni M. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertility and Sterility 2013 99 970-978. (doi:10.1016/j.fertnstert.2013.01.086)
16. Lalioti MD. Impact of follicle stimulating hormone receptor variants in fertility. Current Opinion in Obstetrics & Gynecology 2011 23 158-167. (doi:10.1097/GCO.0b013e3283455288)
17. Loutradis D, Theofanakis Ch, Anagnostou E, Mavrogianni D & Partsinevelos GA. Genetic profile of SNP(s) and ovulation induction. Current Pharmaceutical Biotechnology 2012 13 417-425. (doi:10.2174/138920112799361954)
18. Jiang X, Dias JA & He X. Structural biology of glycoprotein hormones and their receptors: insights to signaling. Molecular and Cellular Endocrinology 2013 382 424-451.
19. Coop G, Pickrell JK, Novembre J, Kudaravalli S, Li J, Absher D, Myers RM, Cavalli-Sforza LL, Feldman MW & Pritchard JK. The role of geography in human adaptation. PLoS Genetics 2009 5 e1000500. (doi:10.1371/journal.pgen. 1000500)
20. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, Absher D, Srinivasan BS, Barsh GS, Myers RM, Feldman MW et al. Signals of recent positive selection in a worldwide sample of human populations. Genome Research 2009 19 826-837. (doi:10.1101/gr.087577.108)
21. Mendez FL, Watkins JC & Hammer MF. A haplotype at STAT2 Introgressed from Neanderthals and serves as a candidate of positive selection in Papua New Guinea. American Journal of Human Genetics 2012 91 265-274. (doi:10.1016/j.ajhg. 2012.06.015)
22. Pakendorf B, Novgorodov IN, Osakovskij VL, Danilova AP, Protod'jakonov AP & Stoneking M. Investigating the effects of prehistoric migrations in Siberia: genetic variation and the origins of Yakuts. Human Genetics 2006 120 334-353. (doi:10.1007/s00439-006-0213-2)
23. Pritchard LK, Pickrell JK & Coop G. The genetics of human adaptation: hard sweeps, soft sweeps and polygenic adaptation. Current Biology 2010 20 R208-R2015. (doi:10.1016/j.cub.2009.11.055)
24. Simoni M, Nieschlag E & Gromoll J. Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Human Reproduction Update 2002 8 413-421. (doi:10.1093/humupd/8.5.413)
25. Wunsch A, Ahda Y, Banaz-Yaşar F, Sonntag B, Nieschlag E, Simoni M & Gromoll J. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertility and Sterility 2005 84 446-453. (doi:10.1016/j.fertnstert.2005.02.031)
26. Grigorova M, Rull K & Laan M. Haplotype structure of FSHB, the b-subunit gene for fertility-associated follicle-stimulating hormone: possible influence of balancing selection. Annals of Human Genetics 2007 71 18-28. (doi:10.1111/j.1469-1809.2006.00299.x)
27. Benson CA, Kurz TL & Thackray VG. A human FSHB promoter SNP associated with low FSH levels in men impairs LHX3 binding and basal FSHB transcription. Endocrinology 2013 154 3016-3021. (doi:10.1210/en.2013-1294)
28. Simoni M, Gromoll J, Höppner W, Kamischke A, Krafft T, Stähle D & Nieschlag E. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. Journal of Clinical Endocrinology and Metabolism 1999 84 751-755. (doi:10.1210/jc.84.2.751)
29. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ & Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Molecular Human Reproduction 2002 8 893-899. (doi:10.1093/molehr/8.10.893)
30. Ryan GL, Feng X, d'Alva CB, Zhang M, Van Voorhis BJ, Pinto EM, Kubias AE, Antonini SR, Latronico AC & Segaloff DL. Evaluating the roles of follicle-stimulating hormone receptor polymorphisms in gonadal hyperstimulation associated with severe juvenile primary hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 2312-2317. (doi:10.1210/jc.2006-2086)
31. Nordhoff V, Sonntag B, von Tils D, Götte M, Schüring AN, Gromoll J, Redmann K, Casarini L & Simoni M. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells. Reproductive Biomedicine Online 2011 23 196-203. (doi:10.1016/j.rbmo.2011.04.009)
32. Zalewski G, Wołczyński S & Chyczewski L. Association of rs6166 polymorphism with FSH receptor transcript variants and steroid production in human granulosa cell cultures. Systems Biology in Reproductive Medicine 2013 59 191-198.
33. Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, Makita Y, Hata A, Yamada M, Takahashi N et al. Mutation of the follicle-stimulating hormone receptor gene 5′-untranslated region associated with female hypertension. Hypertension 2006 48 512-518. (doi:10.1161/01.HYP.0000233877. 84343.d7)
34. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR & O'Donovan MC. Functional analysis of human promoter polymorphisms. Human Molecular Genetics 2003 12 2249-2254. (doi:10.1093/hmg/ddg246)
35. Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L & Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 2005 90 4866-4872. (doi:10.1210/jc.2004-2268)
36. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC & Simoni M. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertility and Sterility 2003 80 986-992. (doi:10.1016/S0015-0282(03)01115-4)
37. Falconer H, Andersson E, Aanesen A & Fried G. Follicle-stimulating hormone receptor polymorphisms in a population of infertile women. Acta Obstetricia et Gynecologica Scandinavica 2005 84 806-811. (doi:10.1111/j.0001- 6349.2005.00736.x)
38. Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S & Makrigiannakis A. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. Journal of Assisted Reproduction and Genetics 2006 23 177-184. (doi:10.1007/s10815-005-9015-z)
39. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, Lee GH, Lee WD, Kim SH, Kim JG et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. Journal of Human Genetics 2006 51 665-670. (doi:10.1007/s10038-006-0005-5)
40. Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, Taieb S, Wainer R, Benahmed M, de Mazancourt P et al. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoS ONE 2012 7 e38700. (doi:10.1371/journal.pone.0038700)
41. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV & Mahale SD. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reproductive Biomedicine Online 2009 18 509-515. (doi:10.1016/S1472-6483(10)60127-7)
42. Anagnostou E, Mavrogianni D, Theofanakis Ch, Drakakis P, Bletsa R, Demirol A, Gurgan T, Antsaklis A & Loutradis D. ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Current Pharmaceutical Biotechnology 2012 13 426-434. (doi:10.2174/138920112799361891)
43. Genro VK, Matte U, De Conto E, Cunha-Filho JS & Fanchin R. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to follicle-stimulating hormone administration as assessed by the Follicular Output RaTe (FORT). Journal of Assisted Reproduction and Genetics 2012 29 657-663. (doi:10.1007/s10815-012-9761-7)
44. Klinkert ER, te Velde ER, Weima S, van Zandvoort PM, Hanssen RG, Nilsson PR, de Jong FH, Looman CW & Broekmans FJ. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reproductive Biomedicine Online 2006 13 687-695. (doi:10.1016/S1472-6483(10)60660-8)
45. Rendina D, Gianfrancesco F, De Filippo G, Merlotti D, Esposito T, Mingione A, Nuti R, Strazzullo P, Mossetti G & Gennari L. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. European Journal of Endocrinology 2010 163 165-172. (doi:10.1530/EJE-10- 0043)
46. Vilodre LC, Kohek MB & Spritzer PM. Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in Southern Brazil and associations with phenotype. Journal of Endocrinological Investigation 2008 31 552-557. (doi:10.1103/physreve.64.022101)
47. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, Seliger E, Röpke F, Gromoll J, Nieschlag E et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenetics and Genomics 2005 15 451-456. (doi:10.1097/01.fpc.0000167330.92786.5e)
48. de Koning CH, Benjamins T, Harms P, Homburg R, van Montfrans JM, Gromoll J, Simoni M & Lambalk CB. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Human Reproduction 2006 21 443-446. (doi:10.1093/humrep/dei317)
49. Mohiyiddeen L, Newman WG, Cerra C, McBurney H, Mulugeta B, Roberts SA & Nardo LG. A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertility and Sterility 2013 99 149-155. (doi:10.1016/j.fertnstert.2012.08.037)
50. Desai SS, Roy BS & Mahale SD. Mutations and polymorphisms in FSH receptor: functional implications in human reproduction. Reproduction 2013 146 R235-248. (doi:10.1530/REP-13-0351)
51. Yao Y, Ma CH, Tang HL & Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Molecular Genetics and Metabolism 2011 103 388-393. (doi:10.1016/j.ymgme.2011.04.005)
52. Lledo B, Guerrero J, Turienzo A, Ortiz JA, Morales R, Ten J, Llacer J & Bernabeu R. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenetics and Genomics 2013 23 262-268. (doi:10.1097/FPC.0b013e32835fe813)
53. Desai SS, Achrekar SK, Pathak BR, Desai SK, Mangoli VS, Mangoli RV & Mahale SD. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in granulosa cells. Journal of Clinical Endocrinology and Metabolism 2011 96 2805-2812. (doi:10.1210/jc.2011-1064)
54. Desai SS, Achrekar SK, Paranjape SR, Desai SK, Mangoli VS & Mahale SD. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reproductive Biomedicine Online 2013 27 400-406. (doi:10.1016/j.rbmo. 2013.07.007)
55. Schüring AN, Busch AS, Bogdanova N, Gromoll J & Tüttelmann F. Effects of the FSH-β-subunit promoter polymorphism -211G→T on the hypothalamic-pituitary-ovarian axis in normally cycling women indicate a gender-specific regulation of gonadotropin secretion. Journal of Clinical Endocrinology and Metabolism 2013 98 E82-E86. (doi:10.1210/jc.2012-2780)
56. La Marca A, Papaleo E, Alviggi C, Ruvolo G, De Placido G, Candiani M, Cittadini E, De Michele F, Moriondo V, Catellani V et al. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Human Reproduction 2013 28 1369-1374. (doi:10.1093/humrep/ det061)
57. Hagen CP, Aksglaede L, Sørensen K, Mouritsen A, Mieritz MG, Main KM, Petersen JH, Almstrup K, Rajpert-De Meyts E, Anderson RA et al. FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antiMüllerian hormone in healthy girls: a longitudinal cohort study. Fertility and Sterility 2013 100 1089-1095. (doi:10.1016/j.fertnstert.2013.06. 026)
58. Daelemans C, Smits G, de Maertelaer V, Costagliola S, Englert Y, Vassart G & Delbaere A. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. Journal of Clinical Endocrinology and Metabolism 2004 89 6310-6315. (doi:10.1210/jc.2004-1044)
59. Valkenburg O, Uitterlinden AG, Piersma D, Hofman A, Themmen AP, de Jong FH, Fauser BC & Laven JS. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Human Reproduction 2009 24 2014-2022. (doi:10.1093/humrep/dep113)
60. Grigorova M, Punab M, Poolamets O, Sõber S, Vihljajev V, Zilaitienė B, Erenpreiss J, Matulevičius V, Tsarev I & Laan M. Study in 1790 Baltic men: FSHR Asn680Ser polymorphism affects total testes volume. Andrology 2013 1 293-300. (doi:10.1111/j.2047-2927.2012.00028.x)
61. Tüttelmann F, Laan M, Grigorova M, Punab M, Sõber S & Gromoll J. Combined effects of the variants FSHB -211G>T and FSHR 2039A>G on male reproductive parameters. Journal of Clinical Endocrinology and Metabolism 2012 97 3639-3647. (doi:10.1210/jc.2012-1761)
62. Tüttelmann F, Terwort N, Laan M & Gromoll J. FSHB promotor polymorphism influences male reproductive parameters. Journal für Reproduktionsmedizin und Endokrinolologie 2011 8 305-345.
63. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC & Foresta C. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone β-subunit promoter. Fertility and Sterility 2011 96 1344-1349. (doi:10.1016/j.fertnstert.2011.09.034)
64. Grigorova M, Punab M, Zilaitienė B, Erenpreiss J, Ausmees K, Matuleviĉius V, Tsarev I, Jørgensen N & Laan M. Genetically determined dosage of follicle-stimulating hormone (FSH) affects male reproductive parameters. Journal of Clinical Endocrinology and Metabolism 2011 96 E1534-E1541. (doi:10.1210/jc.2011-0632)
65. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, Vihljajev V & Laan M. Increased prevalence of the -211 T allele of follicle stimulating hormone (FSH) β subunit promoter polymorphism and lower serum FSH in infertile men. Journal of Clinical Endocrinology and Metabolism 2010 95 100-108. (doi:10.1210/jc.2009-1010)
66. Du J, Zhang W, Guo L, Zhang Z, Shi H, Wang J, Zhang H, Gao L, Feng G & He L. Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. Molecular Genetics and Metabolism 2010 100 292-295. (doi:10.1016/j.ymgme.2010.03.018)
67. Binder H, Strick R, Zaherdoust O, Dittrich R, Hamori M, Beckmann MW & Oppelt PG. Assessment of FSHR variants and antiMüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation. Fertility and Sterility 2012 97 1169-1175. (doi:10.1016/j. fertnstert.2012.02.012)
68. de Castro F, Ruiz R, Montoro L, Pérez-Hernández D, Sánchez-Casas Padilla E, Real LM & Ruiz A. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertility and Sterility 2003 80 571-576. (doi:10.1016/S0015-0282(03)00795-7)
69. de Castro F, Morón FJ, Montoro L, Galán JJ, Hernández DP, Padilla ES, Ramírez-Lorca R, Real LM & Ruiz A. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004 14 285-293. (doi:10.1097/00008571-200405000-00003)
70. Gu BH, Park JM & Baek KH. Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome. International Journal of Molecular Medicine 2010 26 107-112. (doi:10.3892/ijmm-00000441)
71. Lazaros LA, Hatzi EG, Pamporaki CE, Sakaloglou PI, Xita NV, Markoula SI, Stefos TI, Zikopoulos KA & Georgiou IA. The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism. Journal of Assisted Reproduction and Genetics 2012 29 1185-1191. (doi:10.1007/s10815-012-9849-0)
72. Livshyts G, Podlesnaja S, Kravchenko S, Sudoma I & Livshits L. A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine. Journal of Assisted Reproduction and Genetics 2009 26 29-34. (doi:10.1007/s10815-008-9279-1)
73. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nature Genetics 2011 43 55-59. (doi:10.1038/ng.732)
74. Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nature Genetics 2012 44 1020-1025. (doi:10.1038/ng.2384)
75. Mutharasan P, Galdones E, Peñalver Bernabé B, Garcia OA, Jafari N, Shea LD, Woodruff TK, Legro RS, Dunaif A & Urbanek M. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. Journal of Clinical Endocrinology and Metabolism 2013 98 E185-E190. (doi:10.1210/jc.2012-2471)
76. Feng Y, Li X & Shao R. Genetic modeling of ovarian phenotypes in mice for the study of human polycystic ovary syndrome. American Journal of Translational Research 2013 5 15-20.
77. Achrekar SK, Modi DN, Meherji PK, Patel ZM & Mahale SD. Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea. Journal of Assisted Reproduction and Genetics 2010 27 317-326. (doi:10.1007/s10815-010-9404-9)
78. Tüttelmann F, Rajpert-De Meyts E, Nieschlag E & Simoni M. Gene polymorphisms and male infertility - a meta-analysis and literature review. Reproductive Biomedicine Online 2007 15 643-658. (doi:10.1016/S1472-6483(10) 60531-7)
79. Wu W, Cai H, Sun H, Lu J, Zhao D, Qin Y, Han X, Niu X, Lu C, Xia Y et al. Follicle stimulating hormone receptor G-29A, 919A>G, 2039A>G polymorphism and the risk of male infertility: a meta-analysis. Gene 2012 505 388-392. (doi:10.1016/j.gene.2012.02.023)
80. Lend AK, Belousova A, Haller-Kikkatalo K, Punab M, Poolamets O, Peters M & Salumets A. Follicle-stimulating hormone receptor gene haplotypes and male infertility in Estonian population and meta-analysis. Systems Biology in Reproductive Medicine 2010 56 84-90. (doi:10.3109/19396360903456676)
81. Ahda Y, Gromoll J, Wunsch A, Asatiani K, Zitzmann M, Nieschlag E & Simoni M. Follicle-stimulating hormone receptor gene haplotype distribution in normozoospermic and azoospermic men. Journal of Andrology 2005 26 494-499. (doi:10.2164/jandrol.04186)
82. Valenti D, La Vignera S, Condorelli RA, Rago R, Barone N, Vicari E & Calogero AE. Follicle-stimulating hormone treatment in normogonadotropic infertile men. Nature Reviews. Urology 2013 10 55-62. (doi:10.1038/nrurol.2012. 234)
83. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A & Foresta C. The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. International Journal of Andrology 2011 34 306-312. (doi:10.1111/j.1365-2605.2010.01086.x)
84. Corbett S & Morin-Papunen L. The polycystic ovary syndrome and recent human evolution. Molecular and Cellular Endocrinology 2013 373 39-50. (doi:10.1016/j.mce.2013.01.001)
85. Plunkett J, Doniger S, Orabona G, Morgan T, Haataja R, Hallman M, Puttonen H, Menon R, Kuczynski E, Norwitz E et al. An evolutionary genomic approach to identify genes involved in human birth timing. PLoS Genetics 2011 7 e1001365. (doi:10.1371/journal.pgen.1001365)
86. Radu A, Pichon C, Camparo P, Antoine M, Allory Y, Couvelard A, Fromont G, Hai MT & Ghinea N. Expression of follicle-stimulating hormone receptor in tumor blood vessels. New England Journal of Medicine 2010 363 1621-1630. (doi:10.1056/NEJMoa1001283)
87. Yang CQ, Chan KY, Ngan HY, Khoo US, Chiu PM, Chan QK, Xue WC & Cheung AN. Sing75 nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis 2006 27 1502-1506. (doi:10.1093/carcin/bgl014)
88. Ferlin A, Pengo M, Selice R, Salmaso L, Garolla A & Foresta C. Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility. Endocrine-Related Cancer 2008 15 429-437. (doi:10.1677/ERC-07-0257)
89. Corbo RM, Gambina G, Broggio E & Scacchi R. Influence of variation in the follicle-stimulating hormone receptor gene (FSHR) and age at menopause on the development of Alzheimer's disease in women. Dementia and Geriatric Cognitive Disorders 2011 32 63-69. (doi:10.1159/000330472)
90. Corbo RM, Pinto A & Scacchi R. Gender-specific association between FSHR and PPARG common variants and human longevity. Rejuvenation Research 2013 16 21-27. (doi:10.1089/rej.2012.1365)